Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeneFIX Prophylaxis vs On-Demand in Hemophilia B
NCT01335061Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2011
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of coagulation factor ix recombinant in hemophilia B (HB), sponsored by Pfizer. Started Sep 2011; status: completed.
02
Drugs
coagulation factor ix recombinant
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT01335061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335061.